Physician profile
Darryn L Appleton
NPI 1740497007
$6,622.01
in general payments reported to CMS, 2019-2025
44 companies · $824 in 2025
The $824 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,373 · 2020: $615 · 2021: $599 · 2022: $758 · 2023: $504 · 2024: $950 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.87 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,483.87 | 2019-2020 | |
| Abbott Laboratories | $819.39 | 2019-2025 | Dragonfly Opstar, Coroflow, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $433.31 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $414.87 | 2021-2025 | |
| Medtronic Vascular, INC. | $352.11 | 2019-2020 | |
| Arineta, INC | $326.39 | 2024 | Spotlight |
| Abiomed | $312.39 | 2019-2024 | Impella |
| Heartflow, INC. | $206.59 | 2019-2025 | |
| Pfizer INC. | $203.55 | 2019-2024 | |
| Medtronic, INC. | $201.26 | 2021-2025 | Signia, Corevalve Evolut R, Ffrangio |
| Boston Scientific Corporation | $167.84 | 2021-2023 | Watchman Flx |
| Atricure, INC. | $145.97 | 2019-2021 | |
| Novo Nordisk INC | $127.10 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.86 | 2020-2025 | Jardiance |
| Amgen INC. | $120.21 | 2023-2025 | Repatha |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryn Appleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.